The merger is a clear positive for CBAN, offering meaningful EPS accretion and expansion into high-growth South Carolina markets. Monitor for regulatory approval timelines and any shareholder dissent. The stock may re-rate as the market prices in the improved scale and profitability profile. Key risk is integration execution and potential for a superior proposal for FSRL.
Price Chart
Executive Summary
Colony Bankcorp (CBAN) announced a definitive merger agreement to acquire First Reliance Bancshares (FSRL) for approximately $163 million in a stock-and-cash transaction. FSRL shareholders can elect $19.75 per share in cash or 0.94 CBAN shares per FSRL share, with a mix of ~80% stock and ~20% cash. The deal is expected to close in Q4 2026, create a ~$5 billion asset bank, and be ~20% accretive to 2027 EPS with a TBVPS earnback of under 3.5 years.
Key Financial Metrics
Key Facts
- CBAN to acquire FSRL in a stock-and-cash deal valued at ~$163 million.
- Consideration: $19.75 cash or 0.94 CBAN shares per FSRL share; ~80% stock / ~20% cash mix.
- Transaction expected to close in Q4 2026, subject to regulatory and shareholder approvals.
- Pro forma combined entity: ~$5.0B in assets, ~$4.0B in deposits, ~$3.2B in loans.
- Deal expected to be ~20% accretive to 2027 EPS with ~12% TBVPS dilution earned back in <3.5 years.
- CBAN's CEO Heath Fountain remains CEO; FSRL CEO Rick Saunders becomes Executive Vice Chairman.
- FSRL director Rick Redden joins CBAN board; FSRL Chairman Dr. Dale Lusk gets board observer rights.
- Termination fee of $6.6 million payable by FSRL in certain scenarios.
- Voting agreements in place with directors and executive officers of both companies.
- CBAN has sufficient capital to fund the cash consideration without external financing.
Financial Impact
Transaction valued at ~$163 million. Expected ~20% accretion to 2027 EPS. ~12% TBVPS dilution with earnback in under 3.5 years. Pre-tax merger expenses of $16.0 million. Cost savings of ~35% of FSRL's projected 2028 non-interest expense (~$37.6M), phased 60% in 2027.
Risk Factors
- Regulatory approval may be delayed or denied, or include burdensome conditions.
- Integration of FSRL's operations and systems may be more costly or difficult than expected.
- Shareholder approval may not be obtained; FSRL shareholders could dissent (threshold <7.5%).
- Cost savings and revenue synergies may not be fully realized or may take longer than anticipated.
- A superior proposal for FSRL could emerge, triggering a termination fee and deal failure.
- CBAN's stock price decline could trigger FSRL's termination right or dilute deal value.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-077342 |
| Document: tm2618469d1_8k.htm | 0001104659-26-077342 |
| Document: tm2618469d1_ex99-3.htm | 0001104659-26-077342 |
| Document: tm2618469d1_ex99-2.htm | 0001104659-26-077342 |
| Document: tm2618469d1_ex99-1.htm | 0001104659-26-077342 |
| Document: 0001104659-26-077342-index-headers.html | 0001104659-26-077342 |
| Document: 0001104659-26-077342-index.html | 0001104659-26-077342 |
| Document: 0001104659-26-077342.txt | 0001104659-26-077342 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 17, 2026 5w ago | 8-K | $20.92 | awaiting T+60 | — | $20.39 (−2.53%) |
Aug 28, 2026 8w ago | EFFECT | $21.34 | awaiting T+60 | — | $20.39 (−4.45%) |
Aug 27, 2026 8w ago | 424B4 | $21.34 | awaiting T+60 | — | $20.39 (−4.45%) |
Aug 25, 2026 8w ago | S-4/A | $21.17 | awaiting T+60 | — | $20.39 (−3.68%) |
Aug 14, 2026 10w ago | S-4 | $22.09 | awaiting T+60 | — | $20.39 (−7.70%) |
Jun 24, 2026 17w ago | 425 | $19.98 $20.71 | ▲ +3.65% | ▼ −0.08% | $20.39 (+2.05%) |
Jun 24, 2026 17w ago | 8-K | $19.98 $20.71 | ▲ +3.65% | ▼ −0.08% | $20.39 (+2.05%) |
Jun 12, 2026 19w ago | Institutional Cluster | $21.12 $21.31 | ▲ +0.90% | ▼ −2.36% | $20.39 (−3.46%) |
Apr 22, 2026 26w ago | 8-K | $19.86 $20.89 | ▲ +5.20% | ▲ +0.18% | $20.39 (+2.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers